Induction Therapy for Locally Advanced, Resectable Cancer of the Esophagus, GE Junction and Gastric Cancer: A Phase I Trial of ZD6474 (Zactima), Paclitaxel, Carboplatin, 5-Fluorouracil, and XRT Followed by Surgery (IRUSZACT0064).
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Vandetanib (Primary) ; Carboplatin; Fluorouracil; Paclitaxel
- Indications Gastric cancer; Oesophageal cancer
- Focus Adverse reactions
- 03 Sep 2010 New trial record